NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
Ajooni Biotech Limited (NSE: AJOONI)
AJOONI Technical Analysis
3
As on 10th Jan 2025 AJOONI SHARE Price closed @ 7.65 and we RECOMMEND Buy for LONG-TERM with Stoploss of 5.92 & Buy for SHORT-TERM with Stoploss of 7.60 we also expect STOCK to react on Following IMPORTANT LEVELS. |
AJOONISHARE Price
Open | 8.15 | Change | Price | % |
High | 8.15 | 1 Day | -0.27 | -3.41 |
Low | 7.57 | 1 Week | -0.39 | -4.85 |
Close | 7.65 | 1 Month | -0.23 | -2.92 |
Volume | 905330 | 1 Year | 0.85 | 12.50 |
52 Week High 69.65 | 52 Week Low 3.35 |
NSE INDIA Most Active Stocks
IDEA | 7.75 | -2.15% |
YESBANK | 17.96 | -2.87% |
SUZLON | 55.57 | -3.99% |
ZOMATO | 242.95 | -0.98% |
GTLINFRA | 1.89 | -2.58% |
ITI | 442.70 | 0.52% |
JPPOWER | 16.20 | -3.97% |
IREDA | 201.15 | -6.91% |
RPOWER | 38.98 | -3.18% |
VAKRANGEE | 34.49 | -5.40% |
NSE INDIA Top Gainers Stocks
NURECA | 380.70 | 17.63% |
CUBEXTUB | 96.84 | 16.31% |
MEGASOFT | 99.10 | 16.15% |
MAZDA | 1969.90 | 13.85% |
KALYANIFRG | 771.00 | 13.80% |
ATLASCYCLE | 112.81 | 9.99% |
DNAMEDIA | 6.99 | 9.91% |
RGL | 179.63 | 6.20% |
RGL | 179.63 | 6.20% |
RGL | 179.63 | 6.20% |
NSE INDIA Top Losers Stocks
SHRIRAMFIN | 532.00 | -81.07% |
LAL | 15.23 | -19.33% |
GTPL | 130.53 | -10.91% |
GRWRHITECH | 4286.15 | -10.14% |
AWL | 291.10 | -10.00% |
JAICORPLTD | 173.00 | -9.99% |
SPANDANA | 405.80 | -9.99% |
DISHTV | 8.86 | -9.87% |
HARRMALAYA | 284.45 | -9.21% |
KAMDHENU | 46.40 | -9.02% |
AJOONI Daily Charts |
AJOONI Intraday Charts |
Whats New @ Bazaartrend |
AJOONI Free Analysis |
|
AJOONI Important Levels Intraday
RESISTANCE | 8.77 |
RESISTANCE | 8.41 |
RESISTANCE | 8.19 |
RESISTANCE | 7.97 |
SUPPORT | 7.33 |
SUPPORT | 7.11 |
SUPPORT | 6.89 |
SUPPORT | 6.53 |
AJOONI Target January 2025
4th UP Target | 17.74 |
3rd UP Target | 15.37 |
2nd UP Target | 13.9 |
1st UP Target | 12.43 |
1st DOWN Target | 8.25 |
2nd DOWN Target | 6.78 |
3rd DOWN Target | 5.31 |
4th DOWN Target | 2.94 |
AJOONI Weekly Target
4th UP Target | 11.16 |
3rd UP Target | 10.16 |
2nd UP Target | 9.54 |
1st UP Target | 8.92 |
1st DOWN Target | 7.16 |
2nd DOWN Target | 6.54 |
3rd DOWN Target | 5.92 |
4th DOWN Target | 4.92 |
AJOONI Target2025
4th UP Target | 18.45 |
3rd UP Target | 15.02 |
2nd UP Target | 12.91 |
1st UP Target | 10.79 |
1st DOWN Target | 4.75 |
2nd DOWN Target | 2.63 |
3rd DOWN Target | 0.52 |
4th DOWN Target | -2.91 |
Ajooni Biotech Limited ( NSE INDIA Symbol : AJOONI )
Sector : N/A And Other Stocks in Same Sector
Sector : N/A And Other Stocks in Same Sector
AJOONI Synopsis Technicals View
50 Day EMA |
N/A (Short Term) |
N/A | |
100 Day EMA | N/A (Mid Term) | N/A | |
200 Day EMA | N/A (Long Term) | N/A | |
MACD (12 26 9) | N/A | N/A | |
RSI (14) | N/A | N/A | |
MFI (14) | N/A | N/A | |
CCI (20) | N/A | N/A | |
WILLIAM %R (14) | N/A | N/A | |
ADX (14) | N/A | N/A | |
PSAR | N/A | N/A | |
10 Day Avg Volume | N/A |
AJOONI Other Details
Segment | EQ | |
Market Capital | 0.00 | |
Sector | ||
Industry | ||
Offical website | > echo $website ; ?> |
AJOONI Address
AJOONI Latest News
AJOONI Business Profile
N/A
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service